Reasons to Retain Stericycle (SRCL) in Your Portfolio Now

The company's revenues for 2024 and 2025 are expected to increase 1.6% and 3.7%, respectively, year over year. Earnings are anticipated to grow 22.8% in 2024 and 16.5% in 2025. The company has an expected longterm (three to five years) earnings per share growth rate of 8%. The services provided by Stericycle usually cannot be delayed and are required routinely. This facilitates the company to achieve a steady revenue flow. It has strong customer relationships, most of which include longterm contracts rangin ...